Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Sino Biopharmaceutical (SBMFF) News Today

Sino Biopharmaceutical logo
$0.99 0.00 (0.00%)
As of 08/22/2025
Compare

SBMFF Latest News

Sino Biopharmaceutical’s Zongertinib Gains Breakthrough Designation in China
August 20, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-zongertinib-gains-breakthrough-designation-in-china?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Declares Interim Dividend for 2025
August 18, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-declares-interim-dividend-for-2025?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 1-Year High - Here's Why
August 15, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-hits-new-1-year-high-heres-why-2025-08-13/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Up 2.3% - Here's Why
August 14, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-up-23-heres-why-2025-08-12/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Reaches New 12-Month High - Here's What Happened
August 8, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-reaches-new-12-month-high-heres-what-happened-2025-08-07/
Sino Biopharmaceutical’s Phase II Trial for Innovative Cancer Drug Approved
August 7, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-phase-ii-trial-for-innovative-cancer-drug-approved?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
August 1, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/sino-biopharmaceutical-schedules-board-meeting-for-interim-results-and-dividend-consideration/ar-AA1JJ24W
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Here's What Happened
July 31, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sets-new-12-month-high-heres-what-happened-2025-07-30/
Sino Biopharmaceutical Advances TQB6411 in Phase I Clinical Trials
July 22, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-advances-tqb6411-in-phase-i-clinical-trials?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Expands with LaNova Medicines Acquisition Update
July 22, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-expands-with-lanova-medicines-acquisition-update?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Gap Down - Should You Sell?
July 21, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-shares-gap-down-should-you-sell-2025-07-21/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Up 23.8% - Still a Buy?
July 18, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-shares-up-238-still-a-buy-2025-07-18/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 1-Year High - Still a Buy?
July 17, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-hits-new-1-year-high-still-a-buy-2025-07-17/
Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million
July 16, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sino-biopharmaceutical-to-acquire-lanova-medicines-for-up-to-951-million/ar-AA1IDOAV
Sino Biopharmaceutical Acquires Full Stake in LaNova Medicines
July 15, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-acquires-full-stake-in-lanova-medicines?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory Acceptance
July 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-new-breast-cancer-treatment-gains-regulatory-acceptance?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Volume Increase - Time to Buy?
July 2, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sees-large-volume-increase-time-to-buy-2025-07-02/
Sino Biopharmaceutical Ltd (1177) - Investing.com UK
July 1, 2025  |  uk.investing.comhttps://uk.investing.com/equities/sino-biopharm
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading 8.7% Higher - Still a Buy?
June 23, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-87-higher-still-a-buy-2025-06-23/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Decline in Short Interest
June 18, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sees-large-decline-in-short-interest-2025-06-18/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 4.4% - Should You Sell?
June 17, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-down-44-should-you-sell-2025-06-17/
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Time to Buy?
June 10, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sets-new-12-month-high-time-to-buy-2025-06-10/
Sino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGM
June 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-secures-shareholder-approval-for-key-resolutions-at-agm?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Still a Buy?
June 4, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sets-new-12-month-high-still-a-buy-2025-06-03/
Sino Biopharmaceutical’s Phase III Study Shows Promising Results for NSCLC Treatment
June 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-phase-iii-study-shows-promising-results-for-nsclc-treatment?utm_source=marketbeat.com&utm_medium=referral
SBMFF Sino Biopharmaceutical Limited
May 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/SBMFF
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 52-Week High - Should You Buy?
May 29, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-sets-new-52-week-high-should-you-buy-2025-05-27/
Sino Biopharmaceutical’s TQB2868 Shows Promise in Pancreatic Cancer Treatment
May 29, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-tqb2868-shows-promise-in-pancreatic-cancer-treatment?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Unveils Promising Phase I Data for TQB2102 at ASCO 2025
May 27, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-unveils-promising-phase-i-data-for-tqb2102-at-asco-2025?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading 5.3% Higher - Time to Buy?
May 14, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-53-higher-time-to-buy-2025-05-12/
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
May 6, 2025  |  msn.comhttps://www.msn.com/en-sg/news/other/trd205-a-first-in-class-pain-drug-moves-to-phase-ii-with-first-patient-dosed/ar-AA1Ee3XE
U.S. FDA Approves China-Produced Cancer Drug
April 28, 2025  |  forbes.comhttps://www.forbes.com/sites/forbeschina/2025/04/27/us-fda-approves-china-produced-cancer-drug/
Sino Biopharmaceutical’s Penpulimab Injection Gains US FDA Approval
April 25, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-penpulimab-injection-gains-us-fda-approval?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 52-Week High - Here's What Happened
April 24, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-hits-new-52-week-high-heres-what-happened-2025-04-22/
Sino Biopharmaceutical to Showcase 45 Research Results at 2025 ASCO Meeting
April 24, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-to-showcase-45-research-results-at-2025-asco-meeting?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Down 79.5% in March
April 16, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-limited-otcmktssbmff-short-interest-down-795-in-march-2025-04-14/
Sino Biopharmaceutical’s TQB3019 Approved for Clinical Trials
April 9, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-tqb3019-approved-for-clinical-trials?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical Receives Approval for Clinical Trial of New Cancer Drug
April 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-receives-approval-for-clinical-trial-of-new-cancer-drug?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical’s TQB6411 Clinical Trial Application Accepted
April 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceuticals-tqb6411-clinical-trial-application-accepted?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading 4.9% Higher - Still a Buy?
March 25, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-49-higher-still-a-buy-2025-03-24/
Sino Biopharmaceutical Reports Positive Phase III Results for Breast Cancer Treatment
March 24, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-reports-positive-phase-iii-results-for-breast-cancer-treatment?utm_source=marketbeat.com&utm_medium=referral
Asian Market Insights: Sino Biopharmaceutical And 2 Other Prominent Penny Stocks
March 20, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/asian-market-insights-sino-biopharmaceutical-040454573.html
Sino Biopharmaceutical Partners with Sciwind for Innovative RSV Treatment
February 27, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-partners-with-sciwind-for-innovative-rsv-treatment?utm_source=marketbeat.com&utm_medium=referral
Discovering Value: 3 Penny Stocks With At Least US$700M Market Cap
February 19, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/discovering-value-3-penny-stocks-021152170.html
Sino Biopharmaceutical Gains Approval for Innovative Tulobuterol Patch
February 6, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sino-biopharmaceutical-gains-approval-for-innovative-tulobuterol-patch?utm_source=marketbeat.com&utm_medium=referral
Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 12.3% - Here's What Happened
January 30, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-otcmktssbmff-trading-down-123-heres-what-happened-2025-01-30/
Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 20.6% in December
December 29, 2024  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sino-biopharmaceutical-limited-otcmktssbmff-short-interest-up-206-in-december-2024-12-29/
3 Promising Penny Stocks With Market Caps Under US$11B
December 23, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/3-promising-penny-stocks-market-110657391.html
Sino Biopharmaceutical’s Promising Liver Cancer Treatment Advancement
November 21, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/sino-biopharmaceutical-s-promising-liver-cancer-treatment-advancement-1034046688
Sino Biopharm Invests in LaNova for Cancer Innovations
November 20, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/sino-biopharm-invests-in-lanova-for-cancer-innovations-1034039313
Get Sino Biopharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

SBMFF Media Mentions By Week

SBMFF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SBMFF
News Sentiment
▼
0.86

0.71
▲
Average
Medical
News Sentiment

SBMFF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SBMFF Articles
This Week
▼
2

1
▲
SBMFF Articles
Average Week

Get Sino Biopharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (OTCMKTS:SBMFF) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel